13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 63 holding rows worth $254,989,593.
- Accession
- 0001387131-23-001890
- Filer
- CIK 1773195
- Filed
- 2023-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 63 entries on the cover page, a total value of $254,989,593 stated on the cover page (in dollars after the unit check, H1), rows summing to $254,989,593 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 818,035 | $21,432,517 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 70,000 | $20,317,500 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 175,000 | $12,591,250 | dollars as filed | put |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 190,767 | $12,523,854 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 70,997 | $8,670,864 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 80,000 | $8,279,200 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 75,000 | $8,250,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 312,498 | $8,165,573 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 240,623 | $7,890,028 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 280,921 | $7,514,637 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 240,143 | $7,439,630 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,143,531 | $7,169,939 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 472,482 | $7,035,257 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 215,000 | $6,781,100 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 90,000 | $5,720,400 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 30,000 | $5,388,600 | dollars as filed | put |
| Amgen Inc. | 031162100 | COM | 20,000 | $5,252,800 | dollars as filed | put |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 45,000 | $5,121,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 258,115 | $5,051,311 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 110,000 | $4,902,700 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 573,678 | $4,715,633 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 60,000 | $4,068,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 87,601 | $4,013,878 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 10,000,000 | $3,895,290 | dollars as filed | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 7,500,000 | $3,410,048 | dollars as filed | principal |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 268,747 | $3,335,150 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 350,000 | $3,290,000 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 60,630 | $3,089,705 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 60,000 | $2,877,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 105,000 | $2,743,650 | dollars as filed | call |
| GERON CORP | 374163103 | COM | 1,056,500 | $2,556,730 | dollars as filed | put |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 100,000 | $2,545,000 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 375,000 | $2,396,250 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 250,000 | $2,350,000 | dollars as filed | call |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 661,264 | $2,248,298 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 193,064 | $2,231,820 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 303,218 | $2,210,459 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 200,000 | $2,056,000 | dollars as filed | put |
| GERON CORP | 374163103 | COM | 837,000 | $2,025,540 | dollars as filed | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 50,000 | $1,971,500 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 5,000 | $1,894,150 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 25,000 | $1,833,750 | dollars as filed | call |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 247,891 | $1,821,999 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 1,492,771 | $1,522,626 | dollars as filed | |
| PRECIGEN INC | 46122TAA0 | NOTE 3.500% 7/0 | 1,500,000 | $1,487,981 | dollars as filed | principal |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 460,328 | $1,427,017 | dollars as filed | |
| Esperion Therapeutics Inc | 29664WAB1 | NOTE 4.000%11/15/25 | 2,500,000 | $1,363,928 | dollars as filed | principal |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 188,292 | $1,272,854 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 150,000 | $1,237,500 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 92,170 | $1,068,250 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 650,000 | $1,066,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 80,000 | $878,400 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 40,000 | $780,000 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 109,991 | $701,743 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 5,000 | $642,550 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 883,654 | $583,653 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 500,000 | $525,000 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 250,000 | $480,000 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $469,882 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 100,000 | $396,000 | dollars as filed | |
| SCILEX HOLDING CO | 80880W114 | *W EXP 11/10/202 | 18,099 | $3,419 | dollars as filed | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 33,333 | $2,933 | dollars as filed | |
| SCILEX HOLDING CO | 80880W106 | COM | 463 | $1,847 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-23-001890 | this filing | 2023-02-13 | acceptance time not in the bulk data set |